1. Home
  2. PRTA vs XPOF Comparison

PRTA vs XPOF Comparison

Compare PRTA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • XPOF
  • Stock Information
  • Founded
  • PRTA 2012
  • XPOF 2017
  • Country
  • PRTA Ireland
  • XPOF United States
  • Employees
  • PRTA N/A
  • XPOF N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • PRTA Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • PRTA 366.6M
  • XPOF 380.7M
  • IPO Year
  • PRTA N/A
  • XPOF 2021
  • Fundamental
  • Price
  • PRTA $7.69
  • XPOF $7.08
  • Analyst Decision
  • PRTA Buy
  • XPOF Buy
  • Analyst Count
  • PRTA 10
  • XPOF 7
  • Target Price
  • PRTA $24.29
  • XPOF $12.93
  • AVG Volume (30 Days)
  • PRTA 955.8K
  • XPOF 746.9K
  • Earning Date
  • PRTA 08-04-2025
  • XPOF 08-07-2025
  • Dividend Yield
  • PRTA N/A
  • XPOF N/A
  • EPS Growth
  • PRTA N/A
  • XPOF N/A
  • EPS
  • PRTA N/A
  • XPOF N/A
  • Revenue
  • PRTA $10,341,000.00
  • XPOF $316,841,000.00
  • Revenue This Year
  • PRTA N/A
  • XPOF $1.62
  • Revenue Next Year
  • PRTA $122.46
  • XPOF $6.11
  • P/E Ratio
  • PRTA N/A
  • XPOF N/A
  • Revenue Growth
  • PRTA N/A
  • XPOF N/A
  • 52 Week Low
  • PRTA $4.32
  • XPOF $6.64
  • 52 Week High
  • PRTA $23.66
  • XPOF $18.87
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 70.62
  • XPOF 25.62
  • Support Level
  • PRTA $6.61
  • XPOF $9.92
  • Resistance Level
  • PRTA $8.01
  • XPOF $10.71
  • Average True Range (ATR)
  • PRTA 0.40
  • XPOF 0.54
  • MACD
  • PRTA 0.10
  • XPOF -0.35
  • Stochastic Oscillator
  • PRTA 81.40
  • XPOF 2.67

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: